Published in Eur J Gastroenterol Hepatol on March 01, 1999
Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol (2009) 1.42
Etiology and diagnosis of acute biliary pancreatitis. Nat Rev Gastroenterol Hepatol (2010) 0.89
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut (1996) 2.41
Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys (1985) 2.08
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res (2001) 1.88
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol (1998) 1.49
Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis. Scand J Gastroenterol (2001) 1.47
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene (2001) 1.46
Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology (1997) 1.43
Primary sclerosing cholangitis mimicking choledocal cyst type 1 in a young patient. Endoscopy (1999) 1.41
[Hepatosplenomegaly]. Internist (Berl) (1994) 1.40
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut (2002) 1.40
[Therapy of chronic pancreatitis]. Dtsch Med Wochenschr (1996) 1.39
Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Nutr (2008) 1.38
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology (2005) 1.34
Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci (1996) 1.34
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene (2009) 1.32
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene (2001) 1.22
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis (1999) 1.20
Enteral long-term nutrition via percutaneous endoscopic gastrostomy (PEG) in 210 patients: a four-year prospective study. Dig Dis Sci (1998) 1.17
Hyperthermia induces heat shock protein expression and protection against cerulein-induced pancreatitis in rats. Gastroenterology (1996) 1.14
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol (2001) 1.13
S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology (1999) 1.12
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut (2002) 1.11
Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. Eur J Clin Pharmacol (1988) 1.07
Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet (2001) 1.06
Functional expression of HGF and its receptor in human colorectal cancer. Digestion (2000) 1.05
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab. Pharmacogenomics J (2002) 1.05
Pancreatic enzyme response to secretin and cholecystokinin-pancreozymin in the rat. J Physiol (1973) 1.05
Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas (1997) 1.03
Mechanisms in failure of infliximab for Crohn's disease. Lancet (2000) 1.03
Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol (1989) 1.02
[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J (2005) 1.01
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Dtsch Med Wochenschr (1975) 1.01
Chylous cardiac tamponade in acute pancreatitis. Dig Dis Sci (1996) 1.01
The pancreatic secretion of enzymes in rats treated with soybean diet. Scand J Gastroenterol (1974) 1.00
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. Eur J Clin Pharmacol (1988) 1.00
p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc (2001) 0.99
Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol (1978) 0.98
Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology (2003) 0.98
Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease. Gastroenterology (1998) 0.98
Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man. Scand J Gastroenterol Suppl (1985) 0.98
CCK-B/gastrin receptors in human colorectal cancer. Eur J Clin Invest (2001) 0.98
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol (1991) 0.98
[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]. Z Gastroenterol (2004) 0.97
Hydro-jet cutting: a method for selective surgical dissection of nerve tissue. An experimental study on the sciatic nerve of rats. J Craniomaxillofac Surg (1999) 0.97
Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut (1999) 0.97
Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology (1987) 0.96
Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion (1986) 0.96
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol (1999) 0.96
[Pancreatitic pseudocyst with vena cava erosion, necrotizing panniculitis and polyarthropathy]. Pathologe (1986) 0.96
Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells. FEBS Lett (2001) 0.95
[Interlaboratory trial 2000 " Immunohistochemistry" of the German Society for Pathology and the Professional Association of German Pathologists]. Pathologe (2003) 0.95
The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition. Oncogene (2007) 0.94
[Intestinal lymphoma. A long diagnostic path]. Med Klin (Munich) (1999) 0.94
Somatostatin therapy of acute experimental pancreatitis. Gut (1977) 0.93
[Types of death: the thanatologic bridge between principle disease and cause of death]. Pathologe (1988) 0.93
Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases. Oncogene (2006) 0.93
RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. Biochem Biophys Res Commun (2001) 0.93
Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells. Regul Pept (2001) 0.93
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial. Ann Oncol (2011) 0.93
Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes (2004) 0.93
TGFbeta1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro. Regul Pept (2000) 0.92
Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol (2007) 0.91
c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas (1997) 0.91
Plasma cholecystokinin levels in patients with chronic pancreatitis. Digestion (1985) 0.90
Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci U S A (1996) 0.89
Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer (1990) 0.89
Influence of secretin on the course of acute experimental pancreatitis in rats. Digestion (1983) 0.89
Structure/activity characterization of glucagon-like peptide-1. Eur J Biochem (1994) 0.89
Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept (2001) 0.88
GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1. Regul Pept (1996) 0.88
Red kidney bean lectin is a potent cholecystokinin releasing stimulus in the rat inducing pancreatic growth. Gut (1997) 0.87
Effect of a soybean diet on enzyme content and ultrastructure of the rat exocrine pancreas. Digestion (1974) 0.87
PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line. Cancer Res (1996) 0.87
Yersinia enterocolitica infection with multiple liver abscesses uncovering a primary hemochromatosis. Scand J Gastroenterol (2001) 0.87
Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. J Mol Endocrinol (1993) 0.87
Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med (1987) 0.87
Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab (1996) 0.87
Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. Pancreas (1990) 0.86
Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy. Fam Pract (2002) 0.86
Effects of gastrointestinal hormones and carbamylcholine on cAMP accumulation in isolated pancreatic duct fragments from the rat. Digestion (1980) 0.86
Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr (2005) 0.86
Heat shock response is associated with protection against acute interstitial pancreatitis in rats. Dig Dis Sci (2000) 0.85
Treatment of Weber-Christian panniculitis with cyclosporine A. Rheumatol Int (1987) 0.85
[Primary aortoduodenal fistula as a late complication of para-aortic radiation therapy. A case report]. Chirurg (2002) 0.85
Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats. Digestion (1989) 0.85
Regulation of pancreatic growth. Clin Gastroenterol (1984) 0.85
Isolation, long-term culture, and characterization of rat pancreatic fibroblastoid/stellate cells. Pancreas (2001) 0.85
Cardiac tamponade--a rare complication in acute pancreatitis. Z Gastroenterol (1997) 0.85
[Diagnosis of chronic pancreatitis]. Dtsch Med Wochenschr (1996) 0.85